DJCO DailyJournal reports 254 percent Q4 2025 revenue growth shares add 278 percent in todays trading Prologis Inc PLD Bullish Momentum Signals Point to NearTerm Upside for Industrial REIT Leader STVN Stevanato reports Q4 2025 EPS beat and 75 year over year revenue growth shares fall 161 SAMG Silvercrest Q4 2025 EPS falls short of estimates even as shares edge higher on positive investor sentiment Nucor Corporation NUE Stock Technical Pattern Review Q4 2025 Profit Disappoints Morgan MSQ Stock Momentum Deere Company DE Upcoming Fiscal Q2 2026 Earnings Poised for Potential Upside Surprise XCHG XCH Stock Volume Divergence 026 20260420 BOHB Hawaii Pfd B has no publicly available quarterly earnings or performance metrics for the latest period Eaton EIM Stock Commodity Trade Near Highs 20260420 Is Gaming and GLPI stock forming a breakout today 098 20260422 Sea SE Economic Sensitivity Sea posts minor 07 EPS miss no revenue data out Is Matador MTDR stock consolidating before a move Matador posts 62 EPS surprise topping consensus Is Altisource ASPSZ stock forming a trend channel ASPSZ Earnings Altisource withholds core EPS and revenue metrics Market Recap SP 500 edges lower as major US indices post mild losses Johnson Johnson JNJ Icotyde Partnership Drives Portfolio Expansion and DeRisked Biotech Upside BioLife BLFS Stock Technical Risk Signals Q4 2025 Profit Exceeds Views CO2 Energy NOEMR Stock Downside Risk Evaluation ADPT Adaptive Bio posts narrower than expected Q4 2025 loss shares rise 232 percent on investor optimism FSBC Five Star posts a 68 percent Q4 2025 EPS beat as its stock slips 052 percent in todays session Where is Maiden MHNC stock heading next MHNC Unspecified Quarter Earnings Maiden has no EPS or revenue or analyst estimates SON Sonoco posts Q1 2026 EPS of 12 shares fall 15 percent amid no published consensus earnings estimates RIOT Riot Platforms posts far larger Q4 2025 loss than expected stock drops 29 in todays session Textron Inc TXT Poised for Q1 2026 Earnings Beat Amid Broader Aerospace Defense Sector Tailwinds Johnson Johnson JNJ Undervalued Pharma Leader Offers Defensive Upside Amid Sector Selloff Jim Cramer Backs Staggered Entry